A new treatment option has become available for severe epilepsy: fenfluramine, which is now available on the NHS for children and adults living with Lennox–Gastaut syndrome (LGS).
John Ramsay, Founder and Managing Director of Social-Ability, discusses what rising dementia cases mean for local authorities and social care spending.
A new study, demonstrating how circadian rhythms in heart cells alter daily heart function, may explain why shift workers are vulnerable to heart complications.
Dr Campbell Rogers, Chief Medical Officer at HeartFlow, examines how the healthcare industry can best prepare to combat heart disease in a post-pandemic environment.
Professor Carlos Aguiar, Chair of the European Society of Cardiology (ESC) Communication Committee and spokesperson for Heart Failure, outlines the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure.
Pascale V Guillot from University College London, Elizabeth Garrett Anderson Institute for Women’s Health, explains stem cell and gene therapy to treat osteogenesis imperfecta, but is this hype or hope?
This article describes how the collaboration inspires healthy behaviour change so critical in the prevention of type 2 diabetes and the management of all types of diabetes.
According to a Californian study, people over the age of 40 with type 1 diabetes are likely to experience severe COVID - leading to hospitalisation or death.
